drug samples

celgene

Pharma

Celgene to pay $117M to wrap up Revlimid antitrust claims

With Celgene on the verge of moving under Bristol-Myers Squibb’s umbrella, the drugmaker agreed to settle two antitrust suits for $117 million total.

Kyle Blankenship Aug 1, 2019 10:49am

For an industry traditionally scrutinized for low executive pay one has to wonder what our executives are actually making

Synergy preps reps, pricing for Trulance launch

Mar 6, 2017 9:05am